Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-19FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for oxybutynin chloride extended-release filed by Rising Pharma Holdings, Inc. This approval mak…
-
FDA approval · 2019-08-13FDA Approved: FESOTERODINE FUMARATE — Original Application (Dr.Reddy's Laboratories Inc.,)
The FDA approved fesoterodine fumarate from Dr. Reddy's Laboratories Inc. via an original ANDA for the treatment of overactive bladder sympt…
-
FDA approval · 2019-02-28FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s oxybutynin chloride as an original ANDA (ANDA211655), a generic product.
-
FDA approval · 2018-09-06FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (TruPharma LLC)
The FDA approved an Original Application for oxybutynin chloride from TruPharma LLC. This is a generic formulation for the treatment of over…
-
FDA approval · 2017-12-22FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (KVK-Tech, Inc.)
FDA approved the original application for a generic oxybutynin chloride product from KVK-Tech, Inc. for the treatment of overactive bladder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-12FDA Approved: TOLTERODINE TARTRATE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' tolterodine tartrate as an original application generic, for the treatment of overactive bladder wi…
-
FDA approval · 2017-10-24FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) filed by Allergan, Inc. This decision updates the product labeling.
-
FDA approval · 2017-10-23FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' Original Application for oxybutynin chloride as a generic product for overactive bladder and related urina…
-
FDA approval · 2017-06-26FDA Approved: OXYBUTYNIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for oxybutynin from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the drug.
-
FDA approval · 2017-01-05FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare, Inc. to market oxybutynin chloride as a generic product.
-
FDA approval · 2016-11-17FDA Approved: DARIFENACIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original ANDA for Darifenacin from Torrent Pharmaceuticals Limited. Darifenacin is used to treat overactive bladder, includ…
-
FDA approval · 2016-08-23FDA Approved: TROSPIUM CHLORIDE — Original Application (CIPLA USA INC.,)
The FDA approved Cipla USA's generic Trospium chloride via an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2016-03-03FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)
FDA approval of a supplemental application for OXYTROL FOR WOMEN (oxybutynin) from Allergan, Inc. to modify or expand the product's regulato…
-
FDA approval · 2016-02-29FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Oxybutynin Chloride as a generic product under an Original Application by Accord Healthcare, Inc., for the treatment of overact…
-
FDA approval · 2015-11-04FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA supplemental approval for oxybutynin chloride submitted by Chartwell RX, LLC for an existing generic product.
-
FDA approval · 2015-09-25FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for tolterodine tartrate submitted by Teva Pharmaceuticals USA, Inc. for a generic product.
-
FDA approval · 2015-08-31FDA Approved: TOLTERODINE TARTRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's tolterodine tartrate as an original ANDA, enabling a generic tolterodine tartrate product fo…
-
FDA approval · 2014-07-18FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, Inc.
-
FDA approval · 2014-05-15FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL FOR WOMEN (oxybutynin) submitted by Allergan, Inc. This action updates the product's lab…
-
FDA approval · 2013-08-30FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC.
-
FDA approval · 2013-08-20FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OXYTROL FOR WOMEN (oxybutynin) from Allergan, Inc., updating labeling related to the product.
-
FDA approval · 2013-08-16FDA Approved: OXYTROL FOR WOMEN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Oxytrol for Women (oxybutynin), a transdermal patch for overactive bladder in adult women.
-
FDA approval · 2013-07-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves a supplemental application for trospium chloride (Glenmark Pharmaceuticals Inc., USA).
-
FDA approval · 2013-07-19FDA Approved: MYRBETRIQ — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYRBETRIQ (mirabegron) submitted by Astellas Pharma US, Inc.
-
FDA approval · 2013-07-03FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for OXYTROL (oxybutynin), updating the labeling for the product.